These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 17717432)

  • 41. Level of PAX5 in differential diagnosis of non-Hodgkin's lymphoma.
    Bharti B; Shukla S; Tripathi R; Mishra S; Kumar M; Pandey M; Mishra R
    Indian J Med Res; 2016 May; 143(Supplement):S23-S31. PubMed ID: 27748274
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Activating PAX gene family paralogs to complement PAX5 leukemia driver mutations.
    Hart MR; Anderson DJ; Porter CC; Neff T; Levin M; Horwitz MS
    PLoS Genet; 2018 Sep; 14(9):e1007642. PubMed ID: 30216339
    [TBL] [Abstract][Full Text] [Related]  

  • 43. There Are No Magic Bullets in Hematopathology: Even Immunostains for CD20 and CD3 Can Get You Into Trouble.
    Ferry JA
    Adv Anat Pathol; 2018 Jan; 25(1):14-23. PubMed ID: 28914619
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Polyclonal antibody targeting SOX11 cannot differentiate mantle cell lymphoma from B-cell non-Hodgkin lymphomas.
    Zhang LN; Cao X; Lu TX; Fan L; Wang L; Xu J; Zhang R; Zou ZJ; Wu JZ; Li JY; Xu W
    Am J Clin Pathol; 2013 Dec; 140(6):795-800. PubMed ID: 24225745
    [TBL] [Abstract][Full Text] [Related]  

  • 45. EBF1 drives hallmark B cell gene expression by enabling the interaction of PAX5 with the MLL H3K4 methyltransferase complex.
    Bullerwell CE; Robichaud PP; Deprez PML; Joy AP; Wajnberg G; D'Souza D; Chacko S; Fournier S; Crapoulet N; Barnett DA; Lewis SM; Ouellette RJ
    Sci Rep; 2021 Jan; 11(1):1537. PubMed ID: 33452395
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Lineage determination of CD20- B-Cell neoplasms: an immunohistochemical study.
    Chu PG; Loera S; Huang Q; Weiss LM
    Am J Clin Pathol; 2006 Oct; 126(4):534-44. PubMed ID: 16938666
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Reactivity with TdT in Merkel cell carcinoma: a potential diagnostic pitfall.
    Buresh CJ; Oliai BR; Miller RT
    Am J Clin Pathol; 2008 Jun; 129(6):894-8. PubMed ID: 18480005
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The role of Pax5 in leukemia: diagnosis and prognosis significance.
    Shahjahani M; Norozi F; Ahmadzadeh A; Shahrabi S; Tavakoli F; Asnafi AA; Saki N
    Med Oncol; 2015 Jan; 32(1):360. PubMed ID: 25428382
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Diagnostic importance of CD179a/b as markers of precursor B-cell lymphoblastic lymphoma.
    Kiyokawa N; Sekino T; Matsui T; Takenouchi H; Mimori K; Tang WR; Matsui J; Taguchi T; Katagiri YU; Okita H; Matsuo Y; Karasuyama H; Fujimoto J
    Mod Pathol; 2004 Apr; 17(4):423-9. PubMed ID: 14976526
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Oct2 and Bob1 are sensitive and specific markers in lineage determination of B cell lymphomas with no expression of conventional B cell markers.
    Yin L; Xu J; Li M; Reddy V; Zhou Q; Liu H; Chu P; Zhang Q; Huang Q; Gao Z; Liang X; Wang HY; Pan Z
    Histopathology; 2016 Nov; 69(5):775-783. PubMed ID: 27319306
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pax5: the guardian of B cell identity and function.
    Cobaleda C; Schebesta A; Delogu A; Busslinger M
    Nat Immunol; 2007 May; 8(5):463-70. PubMed ID: 17440452
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Losing B cell identity.
    Carotta S; Nutt SL
    Bioessays; 2008 Mar; 30(3):203-7. PubMed ID: 18293359
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Plasmablastic Lymphoma: A Review of Clinicopathologic Features and Differential Diagnosis.
    Harmon CM; Smith LB
    Arch Pathol Lab Med; 2016 Oct; 140(10):1074-8. PubMed ID: 27684979
    [TBL] [Abstract][Full Text] [Related]  

  • 54. PAX5 is the transcriptional activator of mucolipin-2 (MCOLN2) gene.
    Valadez JA; Cuajungco MP
    Gene; 2015 Jan; 555(2):194-202. PubMed ID: 25445271
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Effect of pax5 gene blocked by RNAi on biological characteristics of B cell malignant lymphoma].
    Yuan XL; Zhang B; Jiang LM; Shen LS
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Aug; 16(4):799-803. PubMed ID: 18718064
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Expression and production of aberrant PAX5 with deletion of exon 8 in B-lineage acute lymphoblastic leukaemia of children.
    Sadakane Y; Zaitsu M; Nishi M; Sugita K; Mizutani S; Matsuzaki A; Sueoka E; Hamasaki Y; Ishii E
    Br J Haematol; 2007 Jan; 136(2):297-300. PubMed ID: 17129225
    [TBL] [Abstract][Full Text] [Related]  

  • 57. PAX5 expression in nonhematopoietic tissues. Reappraisal of previous studies.
    Morgenstern DA; Hasan F; Gibson S; Winyard P; Sebire NJ; Anderson J
    Am J Clin Pathol; 2010 Mar; 133(3):407-15. PubMed ID: 20154279
    [TBL] [Abstract][Full Text] [Related]  

  • 58. An unusual case of biphenotypic, bigenotypic mature lymphoma.
    Koletsa T; Kotoula V; Christoforidou A; Pantelidou P; Petrakis G; Tsatalas C; Kostopoulos I
    J Clin Pathol; 2013 Dec; 66(12):1090-2. PubMed ID: 23794479
    [No Abstract]   [Full Text] [Related]  

  • 59. IRF4 negatively regulates proliferation of germinal center B cell-derived Burkitt's lymphoma cell lines and induces differentiation toward plasma cells.
    Teng Y; Takahashi Y; Yamada M; Kurosu T; Koyama T; Miura O; Miki T
    Eur J Cell Biol; 2007 Oct; 86(10):581-9. PubMed ID: 17651861
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Identification of Pax5 as a target of MTA1 in B-cell lymphomas.
    Balasenthil S; Gururaj AE; Talukder AH; Bagheri-Yarmand R; Arrington T; Haas BJ; Braisted JC; Kim I; Lee NH; Kumar R
    Cancer Res; 2007 Aug; 67(15):7132-8. PubMed ID: 17671180
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.